MAPT and Alzheimer disease: Genetic evidence in animals supports an essential role of tau in the Aβ-driven dementia of AD: knockout of the tau gene rescues learning and memory deficits in APP transgenic AD mouse models [12], a result that suggests that reduction of tau protein may be therapeutic for AD.